Apr 14, 2020

Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine

Australian Journal of General Practice
J Simon BellDarren J Creek

Abstract

There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Prophylactic Treatment
A 19
Hydroxychloroquine

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

The British Journal of Ophthalmology
A G Lee
Archives of Ophthalmology
M Frenkel
BMJ : British Medical Journal
Robin E Ferner, Jeffrey K Aronson
Retinal Cases & Brief Reports
Michael F Marmor
© 2020 Meta ULC. All rights reserved